PROSIGHT MANAGEMENT, LP – Aldeyra Therapeutics, Inc. Transaction History
PROSIGHT MANAGEMENT, LP portfolio value:
$6.46M
portfolio value
PROSIGHT MANAGEMENT, LP quarter portfolio value change:
+33.83%
quarter
Aldeyra Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -39.03% | -775.08K shares | -1.45M | $5.34 | 1.21M |
| Q2 2022 | share | Increase | +41.82% | 585.64K shares | 1.7M | $3.99 | 1.98M |
| Q1 2022 | share | Increase | +21.20% | 244.93K shares | 1.60M | $4.45 | 1.40M |
| Q4 2021 | share | Increase | +57.18% | 420.3K shares | -1.83M | $4.06 | 1.15M |
| Q3 2021 | share | Increase | +23.48% | 139.76K shares | -291K | $8.78 | 735K |
| Q2 2021 | share | Increase | +25.72% | 121.79K shares | 1.11M | $11.33 | 595.23K |
| Q1 2021 | share | Decrease | -47.89% | -435.04K shares | -607K | $11.88 | 473.44K |
| Q4 2020 | share | Decrease | -16.81% | -183.51K shares | -1.86M | $6.86 | 908.48K |
| Q3 2020 | share | Decrease | -32.60% | -528.2K shares | 1.33M | $7.41 | 1.09M |
| Q2 2020 | share | Decrease | -20.40% | -415.14K shares | 1.72M | $4.17 | 1.62M |
| Q1 2020 | share | Increase | +42.50% | 607.06K shares | -3.27M | $2.47 | 2.03M |
| Q4 2019 | share | Increase | +80.74% | 638.04K shares | 4.13M | $5.81 | 1.42M |
| Q3 2019 | share | Increase | +13.23% | 92.30K shares | -23K | $5.27 | 790.22K |
| Q2 2019 | share | Increase | +19.65% | 114.62K shares | -1.07M | $6 | 697.92K |
| Q1 2019 | share | Increase | +44.22% | 178.83K shares | 1.91M | $9.03 | 583.3K |
| Q4 2018 | share | Increase | 0.00% | 404.46K shares | 3.35M | $8.3 | 404.46K |